Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors

Impulsive Aggression Clinical Trial

Official title:
Functional Neuroimaging Study to Validate the Point Subtraction Aggression Paradigm (PSAP) Task in Typically Developing Children (TDC) Aged 8-12 Years

Status Completed

Clinical Trial Summary

The purpose of this non-interventional study is to optimize the point subtraction aggression paradigms (PSAP) task in typically developing children (TDC).

Clinical Trial Description

The PSAP is a behavioral aggression test used to evaluate behavioral response related to impulsive aggression. The task will be combined with functional MRI to establish a reliable BOLD signal during testing in developing healthy subjects (8-12 years old) and, to determine the feasibility to perform the task.

Additionally, the levels of neurotransmitters Glutamate and GABA will be measured using magnetic resonance spectroscopy (MRS). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03615703
Study type	Observational
Source	Supernus Pharmaceuticals, Inc.
Contact
Status	Completed
Phase
Start date	August 10, 2018
Completion date	March 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05351944` - Dialectical Behavioral Therapy Skills for Impulsive Aggression	N/A
Terminated	`NCT03638466` - Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder	Phase 2
Recruiting	`NCT00333931` - Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression	N/A
Completed	`NCT03623477` - Can Cognitive Training Decrease Reactive Aggression?	N/A